EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antiviral Activity of Probenecid and Oseltamivir on Influenza Virus Replication

Jackelyn Murray, David E Martin iD, Fred D Sancilio, Ralph A Tripp iD

Viruses · 2023

DOI: 10.3390/v15122366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Jackelyn Murray und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA. Hauptthemen laut MEDLINE: Influenza, Human, Influenza Vaccines. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Georgia Research Alliance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Influenza can cause respiratory infections, leading to significant morbidity and mortality in humans. While current influenza vaccines offer varying levels of protection, there remains a pressing need for effective antiviral drugs to supplement vaccine efforts. Currently, the FDA-approved antiviral drugs for influenza include oseltamivir, zanamivir, peramivir, and baloxavir marboxil. These antivirals primarily target the virus, making them vulnerable to drug resistance. In this study, we evaluated the efficacy of the neuraminidase inhibitor, oseltamivir, against probenecid, which targets the host cells and is less likely to engender resistance. Our results show that probenecid has superior antiviral efficacy compared to oseltamivir in both in vitro replication assays and in vivo mouse models of influenza infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza, HumanInfluenza VaccinesHumansAnimalsMiceOseltamivirProbenecidAntiviral AgentsEnzyme InhibitorsVirus ReplicationNeuraminidaseDrug Resistance, Viral

Stichwörter der Autor:innen

BALB/c miceOAT3 inhibitorantiviralinfluenzaneuraminidase inhibitorrespiratory epithelial cell

Substanzen

OseltamivirProbenecidInfluenza VaccinesAntiviral AgentsEnzyme InhibitorsNeuraminidase

Autor:innen und Institutionen

  • Department of Infectious Disease, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA.
  • TrippBio, Inc., Jacksonville, FL 32256, USA.

ORCID-Profile: David E Martin, Ralph A Tripp

Förderung

  • Georgia Research Alliance

Zitieren

APA

Murray, J., Martin, D. E., Sancilio, F. D., & Tripp, R. A. (2023). Antiviral Activity of Probenecid and Oseltamivir on Influenza Virus Replication. Viruses. https://doi.org/10.3390/v15122366

Vancouver

Murray J, Martin DE, Sancilio FD, Tripp RA. Antiviral Activity of Probenecid and Oseltamivir on Influenza Virus Replication. Viruses. 2023. doi:10.3390/v15122366

BibTeX
@article{Murray2023,
  author = {Murray, Jackelyn and Martin, David E and Sancilio, Fred D and Tripp, Ralph A},
  title = {Antiviral Activity of Probenecid and Oseltamivir on Influenza Virus Replication},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15122366}
}
Kostenlos starten →